Royce & Associates LP Ligand Pharmaceuticals Inc Transaction History

Royce & Associates LP

$10.5 Billion
Q3 2024

A detailed history of Royce & Associates LP transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Royce & Associates LP holds 6,090 shares of LGND stock, worth $698,157. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,090

Previous 11,086 45.07%

Holding current value

$698,157

Previous $934,000 34.69%

% of portfolio

0.01%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$82.7 - $110.11 $413,169 - $550,109	-4,996 Reduced 45.07%	6,090 $610,000
Q2 2024 Aug 13, 2024	SELL	$68.53 - $87.91 $276,724 - $354,980	-4,038 Reduced 26.7%	11,086 $934,000
Q1 2024 May 13, 2024	SELL	$68.64 - $89.2 $345,739 - $449,300	-5,037 Reduced 24.98%	15,124 $1.11 Million
Q4 2023 Feb 12, 2024	BUY	$49.57 - $72.63 $369,296 - $541,093	7,450 Added 58.61%	20,161 $1.44 Million
Q3 2023 Nov 09, 2023	BUY	$58.86 - $72.67 $372,289 - $459,637	6,325 Added 99.04%	12,711 $761,000
Q2 2023 Aug 07, 2023	BUY	$69.53 - $79.33 $444,018 - $506,601	6,386 New	6,386 $460,000
Q1 2020 May 12, 2020	SELL	$63.37 - $107.88 $28,516 - $48,546	-450 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$96.94 - $113.59 $12,408 - $14,539	-128 Reduced 22.15%	450 $47,000
Q3 2019 Nov 13, 2019	BUY	$86.25 - $120.16 $22,252 - $31,001	258 Added 80.63%	578 $58,000
Q2 2019 Aug 12, 2019	BUY	$107.38 - $129.34 $2,147 - $2,586	20 Added 6.67%	320 $37,000
Q1 2019 May 09, 2019	SELL	$105.93 - $142.47 $1.24 Million - $1.67 Million	-11,700 Reduced 97.5%	300 $38,000
Q4 2018 Feb 11, 2019	BUY	$128.36 - $272.13 $1.54 Million - $3.27 Million	12,000 New	12,000 $1.63 Million
Q1 2018 May 14, 2018	SELL	$138.63 - $182.62 $9,704 - $12,783	-70 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$128.36 - $147.04 $1,026 - $1,176	8 Added 12.9%	70 $10,000
Q3 2017 Nov 13, 2017	BUY	$120.91 - $137.94 $7,496 - $8,552	62	62 $8,000

Others Institutions Holding LGND

# of Institutions

256

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.94B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Ligand Pharmaceuticals Inc Transaction History